MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

Baxter International Inc

Suletud

SektorTervishoid

23.06 0.61

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

22.93

Max

23.08

Põhinäitajad

By Trading Economics

Sissetulek

58M

122M

Müük

185M

2.8B

P/E

Sektori keskmine

86.308

36.442

Dividenditootlus

3.64

Kasumimarginaal

4.342

Töötajad

38,000

EBITDA

137M

462M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+13.08% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

3.64%

3.00%

Järgmine tulemuste avaldamine

30. okt 2025

Järgmine aktsia dividendi kuupäev (ex-date)

28. nov 2025

Turustatistika

By TradingEconomics

Turukapital

-3.3B

11B

Eelmine avamishind

22.45

Eelmine sulgemishind

23.06

Uudiste sentiment

By Acuity

77%

23%

343 / 371 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

Baxter International Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

19. okt 2025, 20:00 UTC

Omandamised, ülevõtmised, äriostud

Infratil Agrees to NZ$437.7 Million Deal to Raise Contact Energy Stake

19. okt 2025, 23:44 UTC

Market Talk

Gold Edges Lower Amid Signs of U.S.-China Trade Tensions Easing -- Market Talk

19. okt 2025, 23:37 UTC

Market Talk

New Zealand's Core CPI Keeps Rate Cut Hopes Alive -- Market Talk

19. okt 2025, 23:36 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street Gains -- Market Talk

19. okt 2025, 23:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

19. okt 2025, 23:09 UTC

Market Talk

Could Rio Tinto, BHP Ally to Defend Iron-Ore Pricing Power? -- Market Talk

19. okt 2025, 22:41 UTC

Omandamised, ülevõtmised, äriostud

Luxury Fashion House Kering Confirms Beauty Deal With L'Oréal -- Barrons.com

19. okt 2025, 22:30 UTC

Tulu

Stock Futures Rise Ahead of Major Week of Earnings -- Barrons.com

19. okt 2025, 22:18 UTC

Market Talk

Gold at $5,000 on Cards as Investors Get Comfortable -- Market Talk

19. okt 2025, 21:50 UTC

Market Talk

Infratil's Contact Stake Buy May Require Bigger Asset Sales -- Market Talk

19. okt 2025, 21:15 UTC

Market Talk

Investors Need to Change Narrative Toward Scales -- Market Talk

19. okt 2025, 19:34 UTC

Omandamised, ülevõtmised, äriostud

Infratil's Contact Shareholding to Rise to 14.3% When Deal Completes

19. okt 2025, 19:34 UTC

Omandamised, ülevõtmised, äriostud

Infratil to Issue New Shares Worth NZ$218.8 Million to TECT at NZ$12.43 Each

19. okt 2025, 19:33 UTC

Omandamised, ülevõtmised, äriostud

Infratil Part-Funding Purchase of Contact Energy Stake With NZ$218.8 Million of Existing Debt

19. okt 2025, 19:32 UTC

Omandamised, ülevõtmised, äriostud

Infratil Acquiring Additional Contact Energy Stake for NZ$8.95/Share

19. okt 2025, 19:32 UTC

Omandamised, ülevõtmised, äriostud

Infratil Acquiring Contact Energy Stake for NZ$437.7 Million

19. okt 2025, 19:31 UTC

Omandamised, ülevõtmised, äriostud

Infratil Acquiring TECT Holdings's Shareholding in Contact Energy

19. okt 2025, 19:31 UTC

Omandamised, ülevõtmised, äriostud

Infratil to Acquire Additional 4.92% Stake in Contact Energy

19. okt 2025, 16:29 UTC

Tulu

Elon Musk Pay Drama Heats Up Ahead of Tesla Earnings -- Barrons.com

19. okt 2025, 11:14 UTC

Tulu

Zijin Mining 3Q Oper Income CNY86.49B; up 8.1% on Year>2899.HK

19. okt 2025, 11:14 UTC

Tulu

Zijin Mining: Higher Sales of Gold, Copper Supported Results >2899.HK

19. okt 2025, 11:14 UTC

Tulu

Zijin Mining 3Q Net CNY14.57B; up 57.1% on Year>2899.HK

18. okt 2025, 13:30 UTC

Omandamised, ülevõtmised, äriostud

Deal Expected to Value Unit at Roughly $4B, Sources Say -- WSJ

18. okt 2025, 13:30 UTC

Omandamised, ülevõtmised, äriostud

Deal Could Be Announced as Soon as Next Week, Sources Say -- WSJ

18. okt 2025, 13:30 UTC

Omandamised, ülevõtmised, äriostud

Gucci Owner Kering Nears $4 Billion Sale of Beauty Unit to L'Oréal -- WSJ

18. okt 2025, 13:30 UTC

Omandamised, ülevõtmised, äriostud

Gucci Parent Kering in Talks to Sell Beauty Business to L'Oréal, Sources Say -- WSJ

18. okt 2025, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

17. okt 2025, 23:25 UTC

Omandamised, ülevõtmised, äriostud

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17. okt 2025, 22:15 UTC

Market Talk

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17. okt 2025, 21:15 UTC

Market Talk

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Baxter International Inc Prognoos

Hinnasiht

By TipRanks

13.08% tõus

12 kuu keskmine prognoos

Keskmine 26.11 USD  13.08%

Kõrge 36 USD

Madal 19 USD

Põhineb 11 Wall Streeti analüütiku instrumendi Baxter International Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

11 ratings

2

Osta

8

Hoia

1

Müü

Tehniline skoor

By Trading Central

30.475 / 31.345Toetus ja vastupanu

Lühikene perspektiiv

Weak Bullish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

343 / 371 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Baxter International Inc

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
help-icon Live chat